Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 -0.03 (-8.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2012 - 2025)

Updated

Vistagen Therapeutics (VTGN) posted Long-Term Debt Issuances of $1.02 million for FY2026 (year ended Mar 31, 2026).

Analysis

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2012 - 2025) Analysis & Trends

Since FY2013, Vistagen Therapeutics has reported Long-Term Debt Issuances for 4 fiscal years.

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 35.4% (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual Long-Term Debt Issuances since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.02 Mn
Jun 30, 2020 224,400.00
Mar 31, 2014 156,000.00
Dec 31, 2013 64,000.00
Mar 31, 2013 1.00 Mn
Dec 31, 2012 972,100.00
API Access

Vistagen Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VTGN&period=max&api_key=YOUR_API_KEY